Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study.

Barin L, Kaufmann M, Salmen A, Kamm CP, Gobbi C, Kuhle J, Pot C, Chan A, Czaplinski A, Ajdacic-Gross V, Rodgers S, Kesselring J, Puhan MA, von Wyl V; Swiss Multiple Sclerosis Registry.

Mult Scler Relat Disord. 2018 Dec 2;28:17-25. doi: 10.1016/j.msard.2018.11.033. [Epub ahead of print]

PMID:
30530118
2.

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey.

Kamm CP, Muehl S, Mircsof D, Müller S, Czaplinski A, Achtnichts L, Stellmes P, Di Virgilio G.

Front Neurol. 2018 Oct 10;9:821. doi: 10.3389/fneur.2018.00821. eCollection 2018.

3.

Real-life long-term effectiveness of fingolimod in Swiss patients with relapsing-remitting multiple sclerosis.

Zecca C, Roth S, Findling O, Perriard G, Bachmann V, Pless ML, Baumann A, Kamm CP, Lalive PH, Czaplinski A.

Eur J Neurol. 2018 May;25(5):762-767. doi: 10.1111/ene.13594. Epub 2018 Mar 6.

4.

Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis.

Wehrum T, Beume LA, Stich O, Mader I, Mäurer M, Czaplinski A, Weiller C, Rauer S.

Neurology. 2018 Feb 13;90(7):e601-e605. doi: 10.1212/WNL.0000000000004950. Epub 2018 Jan 19.

PMID:
29352101
5.

Stem cells for ALS: An overview of possible therapeutic approaches.

Czarzasta J, Habich A, Siwek T, Czapliński A, Maksymowicz W, Wojtkiewicz J.

Int J Dev Neurosci. 2017 Apr;57:46-55. doi: 10.1016/j.ijdevneu.2017.01.003. Epub 2017 Jan 11. Review.

PMID:
28088365
6.

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.

Zörner B, Filli L, Reuter K, Kapitza S, Lörincz L, Sutter T, Weller D, Farkas M, Easthope CS, Czaplinski A, Weller M, Linnebank M.

Mult Scler. 2016 Oct;22(11):1463-1475. Epub 2016 Jan 13.

7.

Solitary tumour-like mass lesions of the central nervous system: Primary angiitis of the CNS and inflammatory pseudotumour.

Killeen T, Jucker D, Went P, Muthurajah V, Woon K, Cesnulis E, Czaplinski A.

Clin Neurol Neurosurg. 2015 Aug;135:34-7. doi: 10.1016/j.clineuro.2015.05.008. Epub 2015 May 16. No abstract available.

PMID:
26010394
8.

A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.

Ramseier SP, Roth S, Czaplinski A.

BMC Pharmacol Toxicol. 2015 Apr 1;16:7. doi: 10.1186/s40360-015-0006-0.

9.

Extradural spinal cavernous malformation: a rare but important mimic.

Killeen T, Czaplinski A, Cesnulis E.

Br J Neurosurg. 2014 Jun;28(3):340-6. doi: 10.3109/02688697.2013.841858. Epub 2013 Sep 27.

PMID:
24073758
10.

Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).

Preiningerova JL, Baumhackl U, Csepany T, Czaplinski A, Deisenhammer F, Derfuss T, Fabjan TH, Fazekas F, Fuchs S, Havrdova E, Ledinek AH, Illes Z, Jazbec SS, Klimova E, Komoly S, Kurca E, Linnebank M, Lisy L, Mares J, Prochazkova L, Csilla R, Szilasiova J, Stourac P, Talab R, Turcani P, Vachova M, Vecsei L, Vodusek D, Zapletalova O, Berger T.

CNS Neurosci Ther. 2013 May;19(5):302-6. doi: 10.1111/cns.12101.

PMID:
23607697
11.

ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival.

Weber M, Neuwirth C, Thierbach J, Schweikert K, Czaplinski A, Petersen J, Jung HH, Birve A, Marklund SL, Andersen PM.

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):351-3. doi: 10.1136/jnnp.2011.241349. Epub 2011 Jun 23. No abstract available.

PMID:
21700728
12.

Inter-rater reliability of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in critically ill patients: a prospective observational study.

Fischer M, Rüegg S, Czaplinski A, Strohmeier M, Lehmann A, Tschan F, Hunziker PR, Marsch SC.

Crit Care. 2010;14(2):R64. doi: 10.1186/cc8963. Epub 2010 Apr 14.

13.

Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome.

Sutter R, Mengiardi B, Lyrer P, Czaplinski A.

Neuromuscul Disord. 2009 Oct;19(10):709-10. doi: 10.1016/j.nmd.2009.06.370. Epub 2009 Jul 18.

PMID:
19616949
14.

Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.

Kuhle J, Lindberg RL, Regeniter A, Mehling M, Steck AJ, Kappos L, Czaplinski A.

Eur J Neurol. 2009 Jun;16(6):771-4. doi: 10.1111/j.1468-1331.2009.02560.x. Epub 2009 Feb 19.

PMID:
19236470
15.

Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.

Steck AJ, Czaplinski A, Renaud S.

Neurotherapeutics. 2008 Oct;5(4):528-34. doi: 10.1016/j.nurt.2008.08.012. Review.

16.

Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.

D'Souza M, Kappos L, Czaplinski A.

J Neurol Sci. 2008 Nov 15;274(1-2):76-9. doi: 10.1016/j.jns.2008.08.023. Epub 2008 Sep 24. Review.

PMID:
18817932
17.

ALSFRS and appel ALS scores: discordance with disease progression.

Voustianiouk A, Seidel G, Panchal J, Sivak M, Czaplinski A, Yen A, Appel SH, Lange DJ.

Muscle Nerve. 2008 May;37(5):668-72. doi: 10.1002/mus.20977.

PMID:
18288708
18.

Cranial and peripheral neuropathy due to leptomeningeal infiltration in a patient with Waldenstrom's macroglobulinemia.

Sutter R, Arber C, Tichelli A, Steck AJ, Czaplinski A.

J Neurol. 2007 Aug;254(8):1122-3. Epub 2007 Aug 3. No abstract available.

PMID:
17676357
19.

Primary lateral sclerosis presenting with isolated progressive pseudobulbar syndrome.

Becker A, Hardmeier M, Steck AJ, Czaplinski A.

Eur J Neurol. 2007 Aug;14(8):e3. No abstract available.

PMID:
17661996
20.

The value of database controls in pilot or futility studies in ALS.

Czaplinski A, Haverkamp LJ, Yen AA, Simpson EP, Lai EC, Appel SH.

Neurology. 2006 Nov 28;67(10):1827-32.

PMID:
17130417

Supplemental Content

Loading ...
Support Center